Clinical Trial Update: Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. [Phase 3]

View source ↗

Summary

An ongoing Phase 3 trial comparing one-fraction radiotherapy to multifraction radiotherapy in multiple myeloma; trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Lithuanian University of Health Sciences | Conditions: Multiple Myeloma and Malignant Plasma Cell Neoplasms | Phase 3 | Status: UNKNOWN